More SEC Filings
View Older Stories View Newer Stories-
Form 4 WEYERHAEUSER CO For: Feb 12 Filed by: Wold David M
-
Form 5 CHESAPEAKE UTILITIES For: Dec 31 Filed by: MADDOCK PAUL L JR
-
Form 4 DXC Technology Co For: Feb 13 Filed by: Voci Christopher Anthony
-
Form SCHEDULE 13G Navan, Inc. Filed by: Lightspeed Venture Partners X, L.P.
-
Form 5 CHESAPEAKE UTILITIES For: Dec 31 Filed by: Gary Stephanie N
-
Form 4 PennyMac Financial Servi For: Feb 12 Filed by: Tidmore Abbie
-
Form SCHEDULE 13G/A Rubrik, Inc. Filed by: Lightspeed Venture Partners IX, L.P.
-
Form SCHEDULE 13G/A New ERA Energy & Digital Filed by: Zhou Zachary Yi
-
Form 5 CHESAPEAKE UTILITIES For: Dec 31 Filed by: Petrone Sheree M.
-
Form 4 NRX Pharmaceuticals, For: Jan 27 Filed by: Casper Joseph Michael
-
Form 5 CHESAPEAKE UTILITIES For: Dec 31 Filed by: Jaber Lila A
-
Form 3 NRX Pharmaceuticals, For: Jan 27 Filed by: Casper Joseph Michael
-
Form SCHEDULE 13G/A Community Heritage Finan Filed by: BANC FUNDS CO LLC
-
Form SCHEDULE 13G MFS INVESTMENT GRADE Filed by: Almitas Capital LLC
-
Form 4 PennyMac Financial Servi For: Feb 12 Filed by: STARK DEREK
-
Form 5/A UDR, Inc. For: Dec 31 Filed by: CATTANACH KATHERINE A
-
Form 5 CHESAPEAKE UTILITIES For: Dec 31 Filed by: Forsythe Ronald G Jr
-
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Verve Capital Ltd
-
Form 4 HARMONIC INC. For: Feb 15 Filed by: Chu Timothy C
-
Form 5 CHESAPEAKE UTILITIES For: Dec 31 Filed by: Eden Elisabeth A
-
Form SCHEDULE 13G/A DAILY JOURNAL CORP Filed by: RWWM, Inc.
-
Form 4 PennyMac Financial Servi For: Feb 12 Filed by: Perotti Daniel Stanley
-
Form 5 CHESAPEAKE UTILITIES For: Dec 31 Filed by: BRESNAN THOMAS J
-
Form 4 Mineralys Therapeutics, For: Feb 17 Filed by: Rodman David Malcom
-
Form 144 Atlassian Corp Filed by: DUFFY BRIAN
-
Form 5 CHESAPEAKE UTILITIES For: Dec 31 Filed by: Bisaccia Lisa
-
Form SCHEDULE 13G MFS HIGH YIELD MUNICIPAL Filed by: Almitas Capital LLC
-
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: Novo Holdings A/S
-
Form 4 PennyMac Financial Servi For: Feb 12 Filed by: Hendry Gregory L
-
Form 144 Atlassian Corp Filed by: BINZ JOSEPH LEO
-
Form 4 Alphatec Holdings, Inc. For: Feb 12 Filed by: Hunsaker Craig E
-
Form 4 Forge Global Holdings, For: Feb 12 Filed by: Rodriques Kelly
-
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Almitas Capital LLC
-
Form SCHEDULE 13G/A Evotec SE Filed by: Novo Holdings A/S
-
Form 4 WEYERHAEUSER CO For: Feb 12 Filed by: Merle Denise M
-
Form 4 HALOZYME THERAPEUTICS, For: Feb 16 Filed by: Snyder Mark Howard
-
Form 4 HALOZYME THERAPEUTICS, For: Feb 16 Filed by: LaBrosse Nicole
-
Form 144 Atlassian Corp Filed by: RAJAN RAJEEV BASHYAM
-
Form 4 PennyMac Financial Servi For: Feb 12 Filed by: Follette James
-
Form 4 Forge Global Holdings, For: Feb 12 Filed by: Nevin James
-
Form SCHEDULE 13G/A Kyverna Therapeutics, Filed by: Northpond Ventures III, LP
-
Form 4 HALOZYME THERAPEUTICS, For: Feb 16 Filed by: Torley Helen
-
Form 5 UDR, Inc. For: Dec 31 Filed by: CATTANACH KATHERINE A
-
Form SCHEDULE 13G Park Dental Partners, Filed by: AO Partners I, LP
-
Form 4 WEYERHAEUSER CO For: Feb 12 Filed by: Keatley Travis A
-
Form 4 HARMONIC INC. For: Feb 15 Filed by: Ben-Natan Nimrod
-
Form SCHEDULE 13G/A Mereo BioPharma Group Filed by: Northpond Ventures, LP
-
Form 4 Forge Global Holdings, For: Feb 12 Filed by: Dondzila Catherine M
-
Form 4 PennyMac Financial Servi For: Feb 12 Filed by: ELBAUM MARK
-
Form 5 INNOSPEC INC. For: Dec 31 Filed by: BARNES CORBIN

